Schorge JO - Search Results

1

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.

Rathi A, Virmani AK, Schorge JO, Elias KJ, Maruyama R, Minna JD, Mok SC, Girard L, Fishman DA, Gazdar AF. Rathi A, et al. Among authors: schorge jo. Clin Cancer Res. 2002 Nov;8(11):3324-31. Clin Cancer Res. 2002. PMID: 12429618

2

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO. Makarla PB, et al. Among authors: schorge jo. Clin Cancer Res. 2005 Aug 1;11(15):5365-9. doi: 10.1158/1078-0432.CCR-04-2455. Clin Cancer Res. 2005. PMID: 16061849

3

Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.

Lea JS, Coleman R, Kurien A, Schorge JO, Miller DS, Minna JD, Muller CY. Lea JS, et al. Among authors: schorge jo. Am J Obstet Gynecol. 2004 Mar;190(3):674-9. doi: 10.1016/j.ajog.2003.09.036. Am J Obstet Gynecol. 2004. PMID: 15041998

4

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.

Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Schorge JO, et al. Clin Cancer Res. 2004 May 15;10(10):3474-8. doi: 10.1158/1078-0432.CCR-03-0365. Clin Cancer Res. 2004. PMID: 15161704

5

Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.

Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC. Feltmate CM, et al. Among authors: schorge jo. Clin Cancer Res. 2005 Nov 1;11(21):7651-7. doi: 10.1158/1078-0432.CCR-05-1008. Clin Cancer Res. 2005. PMID: 16278384

6

Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.

Gagnon A, Kim JH, Schorge JO, Ye B, Liu B, Hasselblatt K, Welch WR, Bandera CA, Mok SC. Gagnon A, et al. Among authors: schorge jo. Clin Cancer Res. 2008 Feb 1;14(3):764-71. doi: 10.1158/1078-0432.CCR-07-0856. Clin Cancer Res. 2008. PMID: 18245537 Free article.

7

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC. Kim JH, et al. Among authors: schorge jo. Clin Cancer Res. 2003 Oct 15;9(13):4782-91. Clin Cancer Res. 2003. PMID: 14581349

8

BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.

Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC. Schorge JO, et al. Cancer Res. 2000 Mar 1;60(5):1361-4. Cancer Res. 2000. PMID: 10728699

9

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Kim JH, et al. Among authors: schorge jo. JAMA. 2002 Apr 3;287(13):1671-9. doi: 10.1001/jama.287.13.1671. JAMA. 2002. PMID: 11926891

10

Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.

Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC. Ye B, et al. Among authors: schorge jo. Clin Cancer Res. 2003 Aug 1;9(8):2904-11. Clin Cancer Res. 2003. PMID: 12912935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters